Statistics for AstraZeneca PLC (id:3195 AZN)

Valuation metrics

Market cap

156.85B

Enterprise value

145.13B

Trailing P/E (ttm)

30.77

Forward P/E

13.94

PEG ratio

13.94

Price/Sales (ttm)

3.06

Price/Book (mrq)

383.02

Enterprise Value/Revenue

3.57

Enterprise Value/EBITDA

9.94

Overview

Shares outstanding

1.55B

Float

1.54B

Shares short

% Held by insiders

0.00%

% Held by institutions

0.51%

Average volume (10 days)

3.72M

Average volume (90 days)

Price summary

52-Week low

9.46K

52-Week high

13.39K

52-Week change

2.81%

Beta

0.18

50-Day moving average

11.31K

200-Day moving average

11.65K

Dividends and splits

Forward annual dividend rate

310.40

Forward annual dividend yield

0.03

Trailing annual dividend rate

2.97%

Trailing annual dividend yield

0.00

5-Year annual dividend yield

2.34

Payout ratio

0.72

Dividend date

Ex-dividend date

August 08th, 2024

Last split factor

2:1

Last split date

Financials

Fiscal year

Fiscal year ends

December 31th, 2023

Most recent quarter (mrq)

September 30th, 2024

Profitability

Profit margin

12.68%

Operating margin

20.40%

Operational effectiveness

Return on assets

8.50%

Return on equity

16.66%

Income statement

Revenue (ttm)

33.04

Revenue per share (ttm)

33.04

Quarterly revenue growth (yoy)

0.04

Gross profit (ttm)

29.82B

EBITDA

12.39B

Net income to common (ttm)

5.16B

Diluted EPS (ttm)

3.27

Quarterly earnings growth (yoy)

4.00%

Balance sheet

Total cash (mrq)

3.92B

Total cash per share (mrq)

3.18

Total debt (mrq)

25.11B

Total Debt/Equity (mrq)

77.47

Current ratio (mrq)

93.20%

Book value per share (mrq)

26.27

Cash flow

Cash flow statement

9.00B

Levered free cash flow (LFCF)

7.55B